drugset / Trial / NCT01551446
Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate the variability of several pharmacodynamic measures of kidney function, cardiovascular function, cerebral perfusion, and haemodynamics.
Timeline
- Start
- 2012-04-30
- Primary completion
- 2012-11-30
- Completion
- 2012-11-30
Outcome
Outcome not reported
Stopped: “IDMC recommendation for safety concerns”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bardoxolone methyl | Small molecule | 20 mg | Oral |